71 related articles for article (PubMed ID: 20152973)
1. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania.
Ngoma T; Muwonge R; Mwaiselage J; Kawegere J; Bukori P; Sankaranarayanan R
Int J Gynaecol Obstet; 2010 May; 109(2):100-4. PubMed ID: 20152973
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China.
Li R; Lewkowitz AK; Zhao FH; Zhou Q; Hu SY; Qiu H; Zhang Y; Jiang HW; Zhang JS; Li M; Tong SM; Zhang QY; Qiao YL
Arch Gynecol Obstet; 2012 Jun; 285(6):1627-32. PubMed ID: 22222723
[TBL] [Abstract][Full Text] [Related]
3. Implementation of visual inspection with acetic acid and Lugol's iodine for cervical cancer screening in rural China.
Hu SY; Zhao XL; Zhao FH; Wei LH; Zhou Q; Niyazi M; Liu JH; Wang CY; Li LY; Cheng XD; Duan XZ; Sauvaget C; Qiao YL; Sankaranarayanan R
Int J Gynaecol Obstet; 2023 Feb; 160(2):571-578. PubMed ID: 35871356
[TBL] [Abstract][Full Text] [Related]
4. Web-based instrument to assess skills in visual inspection of the cervix among healthcare providers.
Negulescu RA; Catarino R; De Vuyst H; Undurraga-Malinverno M; Meyer-Hamme U; Alec M; Campana A; Vassilakos P; Petignat P
Int J Gynaecol Obstet; 2016 Jul; 134(1):107-13. PubMed ID: 27126908
[TBL] [Abstract][Full Text] [Related]
5. Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania.
Koneru A; Jolly PE; Blakemore S; McCree R; Lisovicz NF; Aris EA; Mtesigwa T; Yuma S; Mwaiselage JD
Int J Gynaecol Obstet; 2017 Jul; 138(1):53-61. PubMed ID: 28391628
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
Ngwibete A; Ogunbode O; Swende LT; Agbada MM; Omigbodun A
Pan Afr Med J; 2024; 47():50. PubMed ID: 38681110
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.
Makuza JD; Nsanzimana S; Muhimpundu MA; Pace LE; Ntaganira J; Riedel DJ
Pan Afr Med J; 2015; 22():26. PubMed ID: 26664527
[TBL] [Abstract][Full Text] [Related]
8. Smartphone-Enhanced Training, QA, Monitoring, and Evaluation of a Platform for Secondary Prevention of Cervical Cancer: Opportunities and Challenges to Implementation in Tanzania.
Yeates K; Erwin E; Mtema Z; Magoti F; Nkumbugwa S; Yuma S; Hopman WM; Ferguson A; Oneko O; Macheku G; Mtei AF; Smith C; Andrews L; West N; Dalton M; Newcomb A; Ginsburg O
JCO Glob Oncol; 2020 Jul; 6():1114-1123. PubMed ID: 32692627
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer prevention in reproductive health services: knowledge, attitudes and practices of midwives in Côte d'Ivoire, West Africa.
Tchounga BK; Jaquet A; Coffie PA; Horo A; Sauvaget C; Adoubi I; Guie P; Dabis F; Sasco AJ; Ekouevi DK
BMC Health Serv Res; 2014 Apr; 14():165. PubMed ID: 24721621
[TBL] [Abstract][Full Text] [Related]
10. Can visual cervical screening be sustained in routine health services? Experience from Mali, Africa.
Teguete I; Muwonge R; Traore CB; Dolo A; Bayo S; Sankaranarayanan R
BJOG; 2012 Jan; 119(2):220-6. PubMed ID: 21895956
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.
Mapaona R; Williams V; Musarapasi N; Kibwana S; Maseko T; Chekenyere R; Gumbo S; Mdluli P; Byarugaba H; Galagedera D; Mafukidze A; Hurtado-de-Mendoza A; Adsul P; Bongomin P; Loffredo C; Dlamini X; Bazira D; Ojoo S; Haumba S
PLOS Glob Public Health; 2024; 4(4):e0002760. PubMed ID: 38625931
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided diagnosis of cervical dysplasia using colposcopic images.
Ma JH; You SF; Xue JS; Li XL; Chen YY; Hu Y; Feng Z
Front Oncol; 2022; 12():905623. PubMed ID: 35992807
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-based cervical precancer screening with visual inspection with acetic acid triage to achieve same-day treatments among women living with human immunodeficiency virus infection: test-of-concept study in Ibadan, Nigeria.
Awolude OA; Oyerinde SO; Ayeni AO; Adewole IF
Pan Afr Med J; 2021; 40():48. PubMed ID: 34795828
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
Zuberi Z; Mremi A; Chilongola JO; Semango G; Sauli E
PLoS One; 2021; 16(10):e0259096. PubMed ID: 34705880
[TBL] [Abstract][Full Text] [Related]
15. Uterine cervical neoplasms mass screening at the University Hospital Centre of Libreville, Gabon: Associated factors with precancerous and cancerous lesions.
Woromogo SH; Ambounda Ledaga N; Yagata-Moussa FE; Mihindou AS
PLoS One; 2021; 16(7):e0255289. PubMed ID: 34297784
[TBL] [Abstract][Full Text] [Related]
16. Downstaging of cervical cancer in Tanzania over a 16-year period.
Mattick LJ; Ochs-Balcom HM; Mwaiselage J; Kahesa C; Gard AC; Shalan F; Soliman AS
Cancer Causes Control; 2021 Apr; 32(4):401-407. PubMed ID: 33559768
[TBL] [Abstract][Full Text] [Related]
17. Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16
Orang'o EO; Were E; Rode O; Muthoka K; Byczkowski M; Sartor H; Vanden Broeck D; Schmidt D; Reuschenbach M; von Knebel Doeberitz M; Bussmann H
Infect Agent Cancer; 2020; 15():57. PubMed ID: 33024449
[TBL] [Abstract][Full Text] [Related]
18. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.
Almonte M; Murillo R; Sánchez GI; González P; Ferrera A; Picconi MA; Wiesner C; Cruz-Valdez A; Lazcano-Ponce E; Jerónimo J; Ferreccio C; Kasamatsu E; Mendoza L; Rodríguez G; Calderón A; Venegas G; Villagra V; Tatti S; Fleider L; Terán C; Baena A; Hernández ML; Rol ML; Lucas E; Barbier S; Ramírez AT; Arrossi S; Rodríguez MI; González E; Celis M; Martínez S; Salgado Y; Ortega M; Beracochea AV; Pérez N; Rodríguez de la Peña M; Ramón M; Hernández-Nevarez P; Arboleda-Naranjo M; Cabrera Y; Salgado B; García L; Retana MA; Colucci MC; Arias-Stella J; Bellido-Fuentes Y; Bobadilla ML; Olmedo G; Brito-García I; Méndez-Herrera A; Cardinal L; Flores B; Peñaranda J; Martínez-Better J; Soilán A; Figueroa J; Caserta B; Sosa C; Moreno A; Mural J; Doimi F; Giménez D; Rodríguez H; Lora O; Luciani S; Broutet N; Darragh T; Herrero R
BMJ Open; 2020 May; 10(5):e035796. PubMed ID: 32448795
[TBL] [Abstract][Full Text] [Related]
19. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
20. Call for Systematic Population-Based Cervical Cancer Screening: Findings from Community-Based Screening Camps in Tamil Nadu, India.
Vidhubala E; Shewade HD; Niraimathi AK; Ramkumar S; Ramaswamy G; Nagalekshmi G; Sankar Mahadevan B
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3703-3710. PubMed ID: 31870112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
